Tilray Brands (TLRY) Q3 2026 earnings summary

Executive summary

• Achieved record Q3 net revenue of $206.7 million, up 11% year-over-year, with strong international cannabis growth and the BrewDog acquisition positioning annualized revenue at $1.2 billion.

• Diversified global platform includes leading positions in cannabis (Canada), craft brewing (U.S. and U.K.), medical cannabis, and wellness.

• Operating expenses decreased significantly due to the absence of prior year non-cash impairment charges and lower amortization, selling, litigation, and restructuring costs.

• Integration of BrewDog and partnership with Carlsberg expected to accelerate growth and operational scale.

• Adjusted EBITDA rose 19% to $10.7 million, reflecting improved operating performance and cost discipline.

Financial highlights

• Net revenue reached $206.7 million, an 11% increase year-over-year; gross profit was $55 million, up 6%.

• Adjusted EBITDA rose 19% to $10.7 million; adjusted net income improved to $2.4 million from a $2.9 million loss.

• Net loss was $25.2 million, a significant improvement from a $793.5 million loss last year, mainly due to a prior-year non-cash impairment.

• Ended the quarter with $264.8 million in cash and marketable securities and a net cash position of $3.5 million.

• Gross margin was 27% (down from 28%); cannabis gross margin was 40%, distribution 12%, beverage 32%, and wellness 33%.

Outlook and guidance

• Reaffirmed fiscal 2026 adjusted EBITDA guidance of $62 million–$72 million, representing 13% to 31% growth over fiscal 2025.

• Anticipates continued momentum in international cannabis and beverage segments, with further operational efficiencies and cost savings expected from ongoing integration and scale.

• Strategic initiatives include continued investment in core brands, SKU and geographic rationalization, and expansion into international markets.

• Guidance excludes stock-based compensation, impairments, litigation, restructuring, and other non-recurring items.

• Management monitoring Middle East hostilities for potential impacts on expenses and supply chain.